Its international nonproprietary name is azoximer bromide. Polyoxidonium affects both innate
and acquired immunity, working in a complex way.
Polyoxidonium
It increases the effectiveness of the body’s response to infection at any stage of a disease:
strengthens local immunity
speeds up the body’s immune response
reduces inflammation levels
helps to eliminate toxic substances from the body
reduces the incidence of disease and the risk of complications
THE DRUG
IS USED
IS USED
Usually the drug is used to treat viral diseases, including influenza and acute respiratory viral infections (ARVI). It is prescribed by specialists of different profiles: general practitioners, ENT specialists, pulmonologists, urologists, gynecologists, pediatricians, etc.
Azoximer bromide is included in methodological recommendations on the treatment of a number of diseases, including coronavirus. In addition, Polyoxidonium:
Has shown to have an effect
Randomized, placebo-controlled, double-blind trials have been conducted and their results
published in scientific journals. Besides, data from clinical trials have been pooled and
analyzed in meta-analyses.
Has a high safety profile
Polyoxidonium is a chemically pure drug, so when using it, the risk of allergies is minimal.
It does not accumulate in the body and gently helps the immune system to cope with the load,
increasing the reduced parameters and not affecting the normal ones.
Is approved in Europe
It is included in the Slovak clinical recommendations on the treatment of COVID-19. It is
one of the few Russian drugs used in Europe.